Topics

Companies Related to "ObsEva ditches trial after disappointing late stage results" [Most Relevant Company Matches] - Page: 3 RSS

01:04 EST 28th February 2020 | BioPortfolio

Here are the most relevant search results for "ObsEva ditches trial after disappointing late stage results" found in our extensive corporate database of over 50,000 company records.

Showing "ObsEva ditches trial after disappointing late stage results" Companies 51–75 of 3,500+

Relevant

Vicus Therapeutics, LLC

Vicus Therapeutics is a biopharmaceutical company dedicated to bringing breakthrough therapies to patients with cancer. Vicus' lead investigational therapy, VT-122, is a combination of etodolac and propranolol. VT-122 showed positive results in a Phase 2 clinical trial of lung cancer patients and is currently being evaluated in a Phase 2 clinical trial of liver cancer patients receiving Nexavar ...


Biothera

Biothera, a privately held U.S. biotechnology company, is developing Imprime PGG, a late clinical stage biologic that modulates the immune response to cancer. Data from the most recent randomized phase 2 study of Imprime PGG in first line non-squamous non-small cell lung cancer (NSCLC) was featured as a late-breaking abstract in the Immunotherapy of Cancer...

GlycoMimetics, Inc. and Apollomics, Inc.

GlycoMimetics is a clinical-stage biotechnology company focused on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. GlycoMimetics’ wholly-owned drug candidate, uproleselan, an E-selectin antagonist, was evaluated in a Phase 1/2 clinical tr...


Jennerex Biotherapeutics

Jennerex is a clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class, breakthrough targeted oncolytic products for cancer. The Company's lead product JX-594, currently in an international randomized Phase 2 clinical trial for patients with primary liver cancer, demonstrated promising Phase 1 efficacy and safety results in patients with a diverse a...

Quanticate

Quanticate, with headquarters in Cambridge, MA and London, is the largest global biometrics company with full service clinical trial capabilities. Trusted and respected throughout the industry, Quanticate delivers premium quality clinical trial services, consultancy, highly scalable on- and off-site data management, statistical programming and analysis and medical writing solutions. Dedicated st...

Boston Pharmaceuticals Inc.

Boston Pharmaceuticals (the “Company”) is a clinical stage biopharmaceutical company developing differentiated therapeutics. By leveraging a highly experienced drug development team, Boston Pharmaceuticals is building a portfolio of high value clinical candidates addressing important unmet medical needs. The Company partners with innovative biote...

ImmunSYS, Inc.

ImmunSYS, Inc. is a clinical stage biopharmaceutical company focused on the development of innovative cancer immunotherapy products to improve the lives of patients with late-stage metastatic prostate cancer and other adenocarcinomas. The company’s platform technology, YourVaccx™ utilizes a novel combination of the proprietary ANTIGENerator™ energ...

Durata Therapeutics, Inc.

Durata Therapeutics is a biopharmaceutical company addressing the growing need for new antibiotics to treat infectious diseases. Durata’s lead product candidate, dalbavancin, is in late-stage clinical development, and the Company also has two antibiotic programs in earlier-stage, preclinical research. Durata is supported by a premier team of venture c...

Anesiva, Inc

Anesiva (Nasdaq: ANSV) is a late-stage biopharmaceutical company that seeks to be the leader in the development and commercialization of novel therapeutic treatments for pain. We have four product candidates in various stages of development.

Trial Acceleration Institute, Inc.

Trial Acceleration Institute collaborates with the entire spectrum of clinical trial stakeholders to improve study cycle times. Assisting stakeholders with actionable resolutions to their specific cycle time challenges (from protocol feasibility to patient retention) via the identification and initiation of best-of-class, third-party solutions is the primary mission of Trial Acceleration Institute...

Pipex

Pipex Pharmaceuticals, Inc. (“Pipex”) (OTC: BB: PPEX) is a development-stage, specialty pharmaceutical company that is developing proprietary, late-stage drug candidates for the treatment of neurologic and autoimmune diseases. Our strategy is to exclusively in-license proprietary, clinical-stage drug candidates that have demonstrated clinical efficacy and to complete the further clinical testi...

Lipomics Technologies Inc.

Lipomics Technologies provides industry leading metabolic profiling for drug discovery and development, patient monitoring and personalized medicine. The Company's proprietary analytical technologies generate a comprehensive, accurate and quantitative profile of lipid metabolites. A broad range of bioinformatics and analytical tools map these profiles to activity levels of underlying biochemical p...

Celerion

Celerion is the premier provider of innovative early stage clinical research solutions. Formed through the acquisition of the early stage development operations of MDS Pharma Services, Celerion has a full spectrum of resources to meet the needs of the pharmaceutical, biotechnology and generic industries for Phase 0 through IIa proof-of-concept studies. Fro...

QRxPharma Limited

QRxPharma (ASX: QRX and OTCQX: QRXPY) is a clinical-stage specialty pharmaceutical company focused on the development and commercialisation of therapies for pain management and central nervous system (CNS) disorders. Based on a business strategy to expand the clinical utility and commercial value of marketed and/or existing compounds, QRxPharma's product portfolio includes both late and early sta...

Pipeline Therapeutics

Pipeline Therapeutics is a biopharmaceutical company focused on the development and commercialization of first-in-class small molecules for neuroregeneration, including synaptogenesis, remyelination and axonal repair. The company’s lead product candidate, PIPE-505, is a small molecule gamma secretase inhibitor (GSI) to treat mild-to-moderate sensorineural hearing loss (SNHL) associated with ...

NightstaRx Limited

Nightstar is a leading retinal gene therapy company focused on developing and commercializing novel, potentially curative one-time treatments for patients suffering from rare inherited retinal diseases that would otherwise progress to blindness, and for which there are no other treatment options. Nightstar’s lead program, NSR-REP1, is being developed ...

The Dent Law Firm

Dwain Dent found The Dent Law Firm in 1990. Dent has been recognized as a Texas Superlawyer by Texas Monthly Magazine and as one of the Top 100 Trial Lawyers by the American Trial Lawyers Association. He is board certified in personal injury trial work by the Texas Board of Legal Specialization, the State Bar of Texas and the National Board of Trial Advocacy.

Dong-A PharmTech Co. Ltd., Valenta Pharmaceuticals

Dong-A PharmTech is a late-stage pharmaceutical company incorporated in Korea, focused on the development and commercialization of udenafil worldwide excluding Korea.

Fast Track Systems, Inc.

Fast Track Systems, Inc. As a world-class provider of clinical trial software and professional services to pharmaceutical and biotechnology companies, Fast Track Systems, Inc., provides a true competitive edge in the clinical development process. Whether authoring protocols; planning, negotiating, or managing trial budgets; seeking to drastically reduce trial cycle times; and/or needing to maintai...

Crystalplex

Crystalplex is an early stage company providing cutting-edge, bead-based nanotechnology "PlxBeads" to the biomedical research and medical diagnostic markets. Plxbeads can be used as "molecular barcodes" to monitor complex biological processes in pharmaceutical research or as nanosensors reporting diagnostic results for complex diseases.Crystalplex products will provide test results from smaller sa...

ViRexx Medical

ViRexx Medical Corp. is an Edmonton, Alberta based biotechnology company focused on the development of novel therapeutic products for the treatment of cancer and chronic viral infections. ViRexx's most advanced programs include drug candidates for the treatment of ovarian cancer, chronic Hepatitis B & C and solid tumors. The lead product from the AIT™ platform is OvaRex® MAb, a therapy for lat...

Advanced Vision Therapies, Inc

Advanced Vision Therapies, Inc. (AVT) is focused on the treatment of sight-threatening eye diseases, such as age-related macular degeneration and finding a cure that works. The market, which is of a multi-billion dollar magnitude, and represents significant unmet medical needs, has been underserved by large pharma. Recent clinical trial data suggest that these diseases will be treatable, but with ...

RedHill Biopharma Ltd.

RedHill Biopharma is an Israeli pharmaceutical company focused primarily on acquisition and development of late clinical-stage new formulations of existing drugs. For more information please contact: info@redhillbio.com

Protalex, Inc.

Protalex, Inc. is a clinical stage biopharmaceutical company that is developing a class of biopharmaceutical drugs for treating autoimmune and inflammatory diseases, including but not limited to, rheumatoid arthritis. Protalex’s lead product PRTX-100, which is formulated with a highly-purified form of staphylococcal protein A, has completed a Phase 1b...

Oscient Pharmaceuticals

Oscient Pharmaceuticals Corporation is a commercial-stage biopharmaceutical company marketing two FDA-approved products with its national primary care sales force. ANTARA® (fenofibrate) capsules is indicated for the adjunct treatment of hypercholesterolemia (high blood cholesterol) and hypertriglyceridemia (high triglycerides) in combination with diet. FACTIVE® (gemifloxacin mesylate) tablets is...


More From BioPortfolio on "ObsEva ditches trial after disappointing late stage results"

Quick Search

Corporate Database Quicklinks